SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-320889
Filing Date
2018-11-07
Accepted
2018-11-07 16:08:00
Documents
59
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d609848d10q.htm 10-Q 362334
2 EX-31.1 d609848dex311.htm EX-31.1 10235
3 EX-31.2 d609848dex312.htm EX-31.2 10220
4 EX-32.1 d609848dex321.htm EX-32.1 4181
5 EX-32.2 d609848dex322.htm EX-32.2 4166
  Complete submission text file 0001193125-18-320889.txt   2691085

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20180930.xml EX-101.INS 464345
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20180930.xsd EX-101.SCH 40538
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20180930_cal.xml EX-101.CAL 50550
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20180930_def.xml EX-101.DEF 108142
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20180930_lab.xml EX-101.LAB 300240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20180930_pre.xml EX-101.PRE 201883
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 181166359
SIC: 2834 Pharmaceutical Preparations